145 related articles for article (PubMed ID: 15536394)
1. [Involvement of apoptosis and proinflammatory cytokines in the pathogenesis of anemia in multiple myeloma].
Grzaśko N
Postepy Hig Med Dosw (Online); 2004; 58():364-71. PubMed ID: 15536394
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.
Silvestris F; Cafforio P; Tucci M; Dammacco F
Blood; 2002 Feb; 99(4):1305-13. PubMed ID: 11830480
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of erythroblast apoptosis by malignant plasma cells: a new pathogenetic mechanism of anemia in multiple myeloma.
Silvestris F; Cafforio P; Grinello D; Dammacco F
Rev Clin Exp Hematol; 2002; Suppl 1():39-46. PubMed ID: 12735214
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in understanding the pathogenesis of anemia in multiple myeloma.
Silvestris F; Tucci M; Quatraro C; Dammacco F
Int J Hematol; 2003 Aug; 78(2):121-5. PubMed ID: 12953805
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.
Grzasko N; Dmoszynska A; Hus M; Soroka-Wojtaszko M
Haematologica; 2006 Mar; 91(3):386-9. PubMed ID: 16531263
[TBL] [Abstract][Full Text] [Related]
6. Anemia in multiple myeloma: role of deregulated plasma cell apoptosis.
Tucci M; Grinello D; Cafforio P; Silvestris F; Dammacco F
Leuk Lymphoma; 2002 Aug; 43(8):1527-33. PubMed ID: 12400594
[TBL] [Abstract][Full Text] [Related]
7. Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression.
Silvestris F; Tucci M; Cafforio P; Dammacco F
Blood; 2001 Mar; 97(5):1155-64. PubMed ID: 11222356
[TBL] [Abstract][Full Text] [Related]
8. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis.
Felli N; Pedini F; Zeuner A; Petrucci E; Testa U; Conticello C; Biffoni M; Di Cataldo A; Winkles JA; Peschle C; De Maria R
J Immunol; 2005 Aug; 175(3):1464-72. PubMed ID: 16034083
[TBL] [Abstract][Full Text] [Related]
9. Erythropoiesis and erythropoietin in multiple myeloma.
Beguin Y
Leuk Lymphoma; 1995 Aug; 18(5-6):413-21. PubMed ID: 8528047
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis.
De Maria R; Testa U; Luchetti L; Zeuner A; Stassi G; Pelosi E; Riccioni R; Felli N; Samoggia P; Peschle C
Blood; 1999 Feb; 93(3):796-803. PubMed ID: 9920828
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Bouchnita A; Eymard N; Moyo TK; Koury MJ; Volpert V
Am J Hematol; 2016 Jun; 91(4):371-8. PubMed ID: 26749142
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo.
Liu Y; Pop R; Sadegh C; Brugnara C; Haase VH; Socolovsky M
Blood; 2006 Jul; 108(1):123-33. PubMed ID: 16527892
[TBL] [Abstract][Full Text] [Related]
13. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
14. Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.
Bordini J; Bertilaccio MT; Ponzoni M; Fermo I; Chesi M; Bergsagel PL; Camaschella C; Campanella A
Haematologica; 2015 Jun; 100(6):834-841. PubMed ID: 25715406
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of causes for anemia in patients with multiple myeloma].
Rokicka-Piotrowicz M; Paszkowska M; Król M; Król M; Kuratowska Z
Pol Arch Med Wewn; 2000 Dec; 104(6):843-51. PubMed ID: 11424663
[TBL] [Abstract][Full Text] [Related]
16. Regulation of apoptosis by lethal cytokines in human mesothelial cells.
Catalan MP; Subirá D; Reyero A; Selgas R; Ortiz-Gonzalez A; Egido J; Ortiz A
Kidney Int; 2003 Jul; 64(1):321-30. PubMed ID: 12787425
[TBL] [Abstract][Full Text] [Related]
17. Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells.
Silvestris F; Cafforio P; Calvani N; Dammacco F
Br J Haematol; 2004 Aug; 126(4):475-86. PubMed ID: 15287939
[TBL] [Abstract][Full Text] [Related]
18. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes.
Campioni D; Secchiero P; Corallini F; Melloni E; Capitani S; Lanza F; Zauli G
Am J Pathol; 2005 Feb; 166(2):557-63. PubMed ID: 15681838
[TBL] [Abstract][Full Text] [Related]
20. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
